EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 30 April 2024. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 3.06 for January-March 2024 as against Tk. 2.13 for January-March 2023; Consolidated EPS was Tk. 9.75 for July 2023-March 2024 as against Tk. 8.15 for July 2022-March 2023. Consolidated NOCFPS was Tk. 14.79 for July 2023-March 2024 as against Tk. 9.66 for July 2022-March 2023. Consolidated NAV per share was Tk. 104.17 as on March 31, 2024 and Tk. 95.65 as on March 31, 2023.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 663065b8edb49c4b754cb388
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.